Skip to toolbar

Dow and broader stock-market futures turn positive amid upbeat report on Gilead’s experimental coronavirus treatment

Dow and broader stock-market futures turn positive amid upbeat report on Gilead’s experimental coronavirus treatment

Published: July 10, 2020 at 9:10 a.m. ETBy 

Mark DeCambre

 

  • Email icon
  • Facebook icon
  • Twitter icon
  • Linkedin icon
  • Flipboard icon
  • Print icon
  • Resize icon

Referenced Symbols

U.S. stock-index futures turned positive on Friday after a report from Gilead Sciences indicated that its experimental treatment for coronavirus was seeing positive results in reducing deaths. Futures for the Dow Jones Industrial Average YM00, +0.15% YMU20, +0.15% were up 0.1% at 25,600, those for the S&P 500 index ES00, -0.05% ESU20, -0.05% were trading up 0.1% at 3,144, while Nasdaq-100 futures NQ00, -0.32% NQU20, -0.32% advanced 0.1% at 10,740. Gilead published a report on Friday saying that its antiviral drug remdesivir showed that it reduced the risk of death for coronavirus patients by 62% compared with standard care alone. The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said.

About the Author

Mark DeCambre

Mark DeCambre is MarketWatch’s markets editor. He is based in New York. Follow him on Twitter @mdecambre.Advertisement

Advertisement

Partner Center

Most Popular

Read full story
Social media & sharing icons powered by UltimatelySocial
error

Enjoy this blog? Please spread the word :)

RSS
Follow by Email
LinkedIn
LinkedIn
Share
Scroll to Top